Cancer causes an over-sized physiological reaction in the earliest, most-treatable stages of the disease and IONIQ detects that change.
Your body’s electrical properties change due to the presence of cancer. The IONIQ System collects up to 13,125 data points as it measures these changes to determine the presence of cancer. By operating at the confluence of Electrical Impedance Analytics (EIA) or bioimpedance and Artificial Intelligence (AI), we believe our cutting-edge IONIQ System can non-invasively scan for cancer in the earliest stages of the disease.
Our growing clinical evidence library already spans 7 trials at 25 premier cancer institutions across 3 continents yielding more than 20 million data points.